A clinical trial is the part of medical research where a treatment is tested in people, and it sits inside a longer journey. The journey usually begins with laboratory and animal work, then moves into testing in humans, and ends with regulatory review before a treatment reaches patients.
The human-testing portion is conventionally divided into three phases. Phase 1 uses a small number of participants, often a few dozen, and lasts several months; its purpose is mainly to check safety and find a tolerable dose. Phase 2 uses a few hundred participants and typically runs one to two years, looking at whether the treatment seems to work and continues to be safe. Phase 3 is the largest, often involving hundreds to several thousand participants across many sites, and commonly takes two to four years.
Around these phases sit two other blocks of work. Before any phase begins, the trial must be designed and its protocol written. After the last participant finishes, the data must be analyzed and the results reported. Adding the phases together with design, analysis, and reporting, a typical development program spans roughly six to twelve years, and the surrounding regulatory review can add more.
The important point is not the exact numbers, which vary widely by disease and treatment, but the shape of the timeline: a long, mostly sequential chain in which each stage waits for the one before it.